AllergyTalk

For today’s episode we will be reviewing three articles from the Jan-Feb 2020 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. You can also earn CME credit by listening to this podcast! For information about CME credit, head over to https://college.acaai.org/allergytalk

Article links:

Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate.

Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma.

Unexpected and unintended cure of habit cough by proxy.

Please rate our podcast on iTunes!

Please give us feedback, corrections, and suggestions!

Email feedback to: [email protected]

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Today’s speakers have the following disclosures:

Drs. Lee and Kalangara have nothing to disclose.

Dr. Fineman Speaker: AstraZenca, Boehringer Ingelheim, Shire; Research: Aimmune, DBV, Shire, Regeneron.

In the third of three podcasts focusing on Cough, host Dr. Purvi Parikh joins with Dr. Kevin Murphy and Dr. Mandel Sher to look at the what does and doesn’t work in treating cough. They review the current therapies and what new therapies options are coming in the future.

This podcast is supported by an educational grant from Merck & Co., Inc.

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Today’s speakers have the following disclosures:

Kevin Murphy, MD

Purvi Parikh, MD

Honoraria: AstraZeneca, Takeda, Genentech/Novartis, Aimmune; Contracted research: AstraZeneca

Mandel Sher, MD

Advisory Committee, Consulting Fee: Merck; Speaker, Honorarium: Optinose; Consulting, Fee: NeRRe; Clinical Investigator, Contracted Research: Attenua, Merck, NeRRe

In this, the second of three podcasts focusing on Cough, host Dr. Purvi Parikh discusses diagnosing cough with Dr. Mandel Sher and Dr. Kevin Murphy. They address diagnosing chronic cough in children and adults. Protracted bacterial bronchitis, the role of GERD in cough, and habit cough are also discussed.

This podcast is supported by an educational grant from Merck & Co., Inc.

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Today’s speakers have the following disclosures:

Kevin Murphy, MD

Purvi Parikh, MD

Honoraria: AstraZeneca, Takeda, Genentech/Novartis, Aimmune; Contracted research: AstraZeneca

Mandel Sher, MD

Advisory Committee, Consulting Fee: Merck; Speaker, Honorarium: Optinose; Consulting, Fee: NeRRe; Clinical Investigator, Contracted Research: Attenua, Merck, NeRRe

In this, the first of three podcasts focusing on Cough, host Dr. Purvi Parikh speaks with Dr. Mandel Sher and Dr. Kevin Murphy about the “true” cough reflex, the cough response, and cough hypersensitivity.

This podcast is supported by an educational grant from Merck & Co., Inc.

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Today’s speakers have the following disclosures:

Kevin Murphy, MD

Purvi Parikh, MD

Honoraria: AstraZeneca, Takeda, Genentech/Novartis, Aimmune; Contracted research: AstraZeneca

Mandel Sher, MD

Advisory Committee, Consulting Fee: Merck; Speaker, Honorarium: Optinose; Consulting, Fee: NeRRe; Clinical Investigator, Contracted Research: Attenua, Merck, NeRRe

For this episode, we will be reviewing three articles from the Nov-Dec 2019 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. To subscribe to Allergy Watch, head over to https://college.acaai.org/publications/allergywatch

We’re pleased to introduce CME credit for Allergy Watch episodes of AllergyTalk! For details, head on over to the AllergyTalk webpage at https://college.acaai.org/allergytalk

Article Links:

Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety.

Paired acute-baseline serum tryptase levels in perioperative anaphylaxis: An observational study.

Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects.

Please give us feedback, corrections, and suggestions!

Email feedback to: [email protected]

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Today’s speakers have the following disclosures:

Drs. Lee and Kalangara have nothing to disclose.

Dr. Fineman: Speaker: AstraZenca, Boehringer Ingelheim, Shire; Research: Aimmune, DBV, Shire, Regeneron.

For this episode, we will be reviewing three articles about asthma from the Nov-Dec 2019 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. To subscribe to Allergy Watch, head over to https://college.acaai.org/publications/allergywatch

We’re pleased to introduce CME credit for Allergy Watch episodes of AllergyTalk! For details, head on over to the AllergyTalk webpage at https://college.acaai.org/allergytalk

Article Links:

Racial disparities in asthma-related health care use in the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

Omega-3 and Omega-6 Intake Modifies Asthma Severity and Response to Indoor Air Pollution in Children. 

Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma. 

Please give us feedback, corrections, and suggestions!

Email feedback to: [email protected]

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Today’s speakers have the following disclosures:

Drs. Lee and Kalangara have nothing to disclose.

Dr. Fineman: Speaker: AstraZenca, Boehringer Ingelheim, Shire; Research: Aimmune, DBV, Shire, Regeneron.

Welcome to Episode 8, part 2 of Allergy Talk! I sat down with my co-host Stan Fineman, MD, MBA, ACAAI to review the practice management resources from the ACAAI!

If you have a topic you’d like to cover in a future podcast, let us know at [email protected].

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Today’s speakers have the following disclosures:

Dr. Fineman Speaker: AstraZenca, Boehringer Ingelheim, Shire; Research: Aimmune, DBV, Shire, Regeneron.

Dr. Lee has no relevant disclosures.

Welcome to Episode 8 of Allergy Talk, a roundup of the latest in the field of Allergy and Immunology by the American College of Allergy, Asthma, and Immunology!

At the 2019 ACAAI Annual Meeting in Houston, Texas we interviewed the leaders of the College on how the ACAAI helps its members and what to expect for 2020! If you have a topic you’d like to cover in a future podcast, let us know at [email protected].

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Today’s speakers have the following disclosures:

Dr. Mahr: 

Research / Consultant / Advisory Board / Speaker / Honorarium:

Aimmune, ALK, AZ, Boeringer-Ingelheim, Kaleo, GSK, 

Dr. Meadows:

Speaker: Regeneron, Pfizer, AZ, GSK, Optinose

Consultant: Aimmune

Dr. Lee:

No relevant disclosures

We are excited to present a special 2 part episode of Allergytalk! Dr. Brian Vickery, the principal investigator of the PALISADE study that led to the first FDA-approved peanut immunotherapy, joins us to discuss his personal story and his thoughts on the future of food immunotherapy! If you have a topic you’d like to cover in a future podcast, let us know at [email protected]

We are excited to present a special 2 part episode of Allergytalk! Dr. Brian Vickery, the principal investigator of the PALISADE study that led to the first FDA-approved peanut immunotherapy, joins us to discuss his personal story and his thoughts on the future of food immunotherapy! If you have a topic you’d like to cover in a future podcast, let us know at [email protected].